Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein HEXIM2 is a transcriptional regulator encoded by the human HEXIM2 gene located on chromosome 17. It acts as a general inhibitor of RNA polymerase II-dependent transcription by being a component of the 7SK small nuclear ribonucleoprotein (snRNP) complex, where it regulates the activity of positive transcription elongation factor b (P-TEFb). HEXIM2 exerts its function by binding to the 7SK snRNA and other protein partners, ultimately modulating transcriptional elongation processes necessary for gene expression. There is no strong evidence supporting HEXIM2 as a direct therapeutic target, nor clear association with disease pathogenesis or known drug interactions based on the currently available information.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein HEXIM2 (HEXIM2).